😀The NIH MRSP program brings such wonderful talent to campus! Kudos to Christin for her dedication to understand what factors modify this incredibly dangerous type of coronary plaque present in patients BEFORE they ever have clinical heart disease. 🔥 @ToddVillinesMD@ElucidBio
Lipid-rich necrotic core (LRNC) is a rupture-prone plaque feature linked with MI. We leveraged machine learning to identify top predictors of LRNC modulation over 1 year in psoriasis. Thank you @NehalMehtaMD @TheBethesdaLabs and amazing co-authors! journals.sagepub.com/doi/10.…
FAT MATTERS. And here, CCTA-derived epicardial adipose tissue measurement make a difference on clinical outcomes.👇🏽 EAT is similar to visceral adipose tissue (VAT) which we have shown to drive coronary artery disease NCB in chronic inflammation🔥 insight.jci.org/articles/vie…
Can a fully automated measurement of EAT volume incorporated into routine interpretation of CCTA improve the risk stratification of patients across several important clinical outcomes? Read more to find out bit.ly/3E3k7Ya@Charis_Oxford @imagingmedsci @NehalMehtaMD
BMI has always been a metric to assess for cardiometabolic risk. Waist:hip ratio performs well and better in chronic inflammation. We have shown the value of CT-measures of visceral vs subcutaneous adipose tissue prior, but now, check out how specific depots of fat matter 👇🏽
➡️Very honored to receive public, competitive, independent funding as principal investigator for our project in Psoriasis from @SaludISCIII
➡️Thanks to the whole team involved @MaruGBarderas@NehalMehtaMD@DrJoelGelfand
➡️Most importantly, thanks to all patiens involved
.@pnatarajanmd, of @MGHHeartHealth, received the Anne Klibanski Award for Excellence in Mentoring. Named after Anne Klibanski, President & CEO of @MassGenBrigham, who has mentored hundreds of faculty members. This award is presented to an exceptional @MGHMedicine research mentor.
In March 2022, Dr. Goyal @monikagoyal123 was named the first endowed chair of Women in Science and Health for her outstanding contributions in biomedical research. Today, she has a special message for Women in Medicine Month! @ChildrensNatl @ELAMprogram #womeninmedicine#adaptcnh
🔥@DrJoelGelfand and I planned four Vascular Inflammation in Psoriasis (VIP) trials to test the impact of treating psoriasis in cardiometabolic diseases. Our final one, VIP-A, was just published in @JAMADerm testing apremilast! #VAT matters ncbi.nlm.nih.gov/pubmed/3612…
🔥👇🏼Congratulations to @monikagoyal123 and the @adaptlab_cnh on earning another @NIH award to continue highly informative studies on how we can improve #healthequity outcomes in medicine. Bravo!👏🏼